Delve Bio
PrivateLast Round
Series A
Jun 20, 2023
Total Funding Raised
$35M
Company Overview
Delve Bio operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in June 2023.
Delve Bio is a biotechnology company that provides a metagenomic next-generation sequencing (mNGS) platform for the unbiased detection of neuro-infectious pathogens in cerebrospinal fluid.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delve Bio Comparables
Compare Delve Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Karius | 80% | |
| Biotia | 79% | |
| bioMérieux | 79% |
For institutional investors. Book with your work email.
Delve Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Delve Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| GV | Series A |
| Perceptive Advisors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 83% MoM, reaching 7.2K.
- Jan 1, 2024
Flagship platform Delve Detect to launch in 2024.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 14, 2026
Delve Bio, Inc. launches Delve Detect Plasma to detect pathogens from a single blood sample, and introduces the test with new clinical data at IDWeek 2026 in District of Columbia on Oct 21st-24th '26.
For institutional investors. Book with your work email.
Delve Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Delve Bio's valuation, stock price, and market status.
Is Delve Bio a public or private company?
Delve Bio is a private company.
What is the current stock price of Delve Bio?
Delve Bio is a private company, so its shares have no public market price. Caplight tracks Delve Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Delve Bio worth (valuation)?
Valuation information for Delve Bio is not publicly available.
Can I buy Delve Bio stock?
Delve Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Delve Bio's last funding round?
Delve Bio's most recent funding round was Series A on June 20, 2023.
Who are the main investors in Delve Bio?
Key investors in Delve Bio include Perceptive Advisors.
Will Delve Bio IPO soon?
No public IPO plans have been announced for Delve Bio.
How can I track Delve Bio secondary market activity?
Caplight tracks bids, offers, and trades in Delve Bio's shares on secondary markets.